People: Bristol-Myers Squibb Co (BMY_p.N)
567.60USD
26 Oct 2011
$0.00 (+0.00%)
$567.60
--
$570.10
$570.10
100
0
$0.00
$570.10
Caforio, Giovanni
Brief Biography
Dr. Giovanni Caforio M.D., is President, U.S. Pharmaceuticals of Bristol-Myers Squibb Co. He was most recently senior vice president, Oncology and Immunology Global Commercialization. From 2007 to 2009 – Senior Vice President, U.S. Oncology, Worldwide Pharmaceuticals, a division of the Company, 2009 to 2010 – Senior Vice President, Oncology, Global Commercialization, 2011 to 2011 – Senior Vice President, Oncology and Immunoscience, Global Commercialization.
Basic Compensation
| Total Annual Compensation, | Long-Term Incentive Plans, | All Other, | Fiscal Year Total, |
|---|---|---|---|
| -- | -- | -- | -- |
Options Compensation
| Quantity | Market Value | |
|---|---|---|
| Excercisable | -- | -- |
| Unexercisable | -- | -- |
| Excercised | -- | -- |
| Name | Fiscal Year Total |
|---|---|
James Cornelius |
10,859,000 |
Lamberto Andreotti |
17,202,000 |
Charles Bancroft |
8,567,310 |
Giovanni Caforio |
-- |
Louis Schmukler |
-- |
Elliott Sigal |
8,343,680 |
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
